Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
Titel:
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
Auteur:
Ohno, S. Chow, L. W. C. Sato, N. Masuda, N. Sasano, H. Takahashi, F. Bando, H. Iwata, H. Morimoto, T. Kamigaki, S. Nakayama, T. Nakamura, S. Kuroi, K. Aogi, K. Kashiwaba, M. Yamashita, H. Hisamatsu, K. Ito, Y. Yamamoto, Y. Ueno, T. Fakhrejahani, E. Yoshida, N. Toi, M.